SABCS Meeting News

Read in-depth coverage of the 2022 Symposium highlighting the biggest sessions, research presentations, discussion topics, and more.

Target Audience

This international symposium is directed primarily towards academic and private physicians and researchers involved in breast cancer in medical, surgical, gynecologic, and radiation oncology, as well as patient advocates and other appropriate health care professionals. We anticipate 8,000 attendees from more than 80 countries.

Meeting Location 

We are very pleased to announce that the San Antonio Breast Cancer Symposium will take place in 2022. The Symposium offers attendees the unique opportunity to participate in person in San Antonio, Texas or virtually.  The dates will be December 6-10, 2022 at the Henry B. Gonzalez Convention Center, 900 E. Market Street, San Antonio, TX 78205 USA.

Contact Information

Sharon Hill, Director, Symposia
Mays Cancer Center 
7979 Wurzbach Road, MC 8224 
San Antonio, TX 78229 USA 
Email: sabcs@uthscsa.edu
Phone: 210-450-1550

Preliminary Schedule

Hours subject to change.

Tuesday, December 6
Program 9:00 AM–6:15 PM

Wednesday, December 7
Program 7:00 AM–6:15 PM
Exhibits 10:00 AM–5:00 PM

Thursday, December 8
Program 7:00 AM–6:15 PM
Exhibits 10:00 AM–5:00 PM

Friday, December 9
Program 7:00 AM–7:00 PM
Exhibits 10:00 AM–5:00 PM

Saturday, December 10
Program 8:00 AM–10:00 AM

Executive Committee

Carlos L. Arteaga, UT Southwestern, Harold C. Simmons Cancer Center, Dallas, TX, Co-Director
Angela DeMichele, University of Pennsylvania, Philadelphia, PA
Margaret Foti, American Association for Cancer Research, Philadelphia, PA
David Gius, UT Health San Antonio MD Anderson Cancer Center, San Antonio, TX
Sharon Hill, UT Health San Antonio MD Anderson Cancer Center, San Antonio, TX (ex-officio)
Virginia G. Kaklamani, UT Health San Antonio MD Anderson Cancer Center, San Antonio, TX, Co-Director
Kate Lathrop, UT Health San Antonio MD Anderson Cancer Center, San Antonio, TX (ex-officio)
Ruben A. Mesa, UT Health San Antonio MD Anderson Cancer Center, San Antonio, TX

Program Planning Committee

Fabrice Andre, Gustave Roussy, Ile de France, France
Carlos L. Arteaga, UT Southwestern, Harold C. Simmons Cancer Center, Dallas, TX
Andrea Barrio, Memorial Sloan Kettering Cancer Center, New York, NY
Thelma Brown, University of Alabama at Birmingham, Birmingham, AL
Carlos Caldás, University of Cambridge, Cambridge, United Kingdom
Christina Curtis, Stanford University, Stanford, CA
Gary C. Chamness, Baylor College of Medicine (Retired), Houston, TX (ex-officio)
Angela DeMichele, University of Pennsylvania, Philadelphia, PA
Rebecca Dent, National Cancer Center, Singapore
Margaret Foti, American Association for Cancer Research, Philadelphia, PA
David Gius, UT Health San Antonio MD Anderson Cancer Center, San Antonio, TX
Shom Goel, Peter MacCallum Cancer Centre, Melbourne, Australia
Virginia G. Kaklamani, UT Health San Antonio MD Anderson Cancer Center, San Antonio, TX
Seema A. Khan, Northwestern University, Chicago, IL
Celina Kleer, University of Michigan Medical School, Ann Arbor, MI
Kate Lathrop, UT Health San Antonio MD Anderson Cancer Center, San Antonio, TX (ex-officio)
Sibylle Loibl, GBG Forschungs GMBH, Neu-Isenburg, Germany
Ann Partridge, Dana-Farber Cancer Institute, Boston, MA
Charles M. Perou, University of North Carolina, Chapel Hill, NC
Manjeet Rao, UT Health San Antonio MD Anderson Cancer Center, San Antonio, TX
Mothaffar Rimawi, Baylor College of Medicine, Houston, TX
Peter Schmid, Bart's Cancer Institute Queen Mary University of London, London, United Kingdom
Kalliopi Siziopikou, Northwestern University, Chicago, IL
Patty Spears, UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC
Melinda Telli, Stanford University School of Medicine, Stanford, CA
Alana Welm, University of Utah Huntsman Cancer Institute, Salt Lake City, UT
Wendy Woodward, UT MD Anderson Cancer Center, Houston, TX
Richard Zellars, Indiana University School of Medicine, Indianapolis, IN

Advocate Financial Assistance

Patient advocates wishing to apply for financial assistance for the 2022 SABCS should contact the Alamo Breast Cancer Foundation for information and an application. Applications are available online. Please see their website for more information and qualifications. Applications must be post-marked by September 1, 2022.

E-mail: Jerry@alamobreastcancer.org
Web: www.alamobreastcancer.org

Awards

Susan G. Komen^® Brinker Award for Scientific Distinction

Established by the Susan G. Komen for the Cure in 1992, the Brinker Award for Scientific Distinction recognizes leading scientists for significant work in advancing research concepts and for clinical application in the fields of breast cancer research, screening or treatment. The award is presented to basic and clinical researchers who have made seminal advances in the fight against breast cancer. In addition, the award recognizes scholars for a specific contribution, a consistent pattern of contributions, or leadership in the field that has had a substantial impact on the fight against breast cancer.

The Brinker Award is to be used to further the recipients' activities in breast cancer research. This award has grown in prominence in the breast cancer community and is a marquee award for Komen for the Cure. The recipients of the Brinker Awards will deliver plenary lectures at the 2022 San Antonio Breast Cancer Symposium.

The William L. McGuire Memorial Lectureship

Dr. William L. McGuire, along with Dr. Charles A. Coltman, founded the San Antonio Breast Cancer Symposium in 1977. The William L. McGuire Memorial Lectureship was established in 1992 to commemorate the significant contributions of Dr. McGuire to oncology medicine. His research played a major role in introducing estrogen receptor assays on breast tumor tissue as a guide to treatment decisions for women with breast cancer. Breast cancer patients everywhere now receive these tests.

The lecturer is selected by the SABCS McGuire Award Committee from persons through a nomination process. The selection is based on the following criteria:

• Lecturers are respected figures with an international reputation.

• They have made significant contributions to the field of breast cancer research.

• They are known as skilled presenters.

• They present a topic of high current interest related to the diagnosis and treatment of breast cancer or to the study of its underlying   mechanisms.

AACR Outstanding Investigator Award for Breast Cancer Research, funded by The Breast Cancer Research Foundation

The AACR Outstanding Investigator Award for Breast Cancer Research is presented to an investigator no more than 50 years of age whose novel and significant work that has had or may have a far-reaching impact on the etiology, detection, diagnosis, treatment, or prevention of breast cancer.

AACR Distinguished Lectureship in Breast Cancer Research

The AACR Distinguished Lectureship in Breast Cancer Research has been established to recognize outstanding science that has inspired or has the potential to inspire new perspectives on the etiology, diagnosis, treatment, or prevention of breast cancer.

Mobile App

Download the 2022 SABCS Mobile App.

Scan the QR Code or go to the Apple App Store or Google Play and search for eventScribe.

Embargo

Abstracts, with the exception of those withheld for SABCS press conferences, will be released approximately one month prior to the symposium. The abstracts withheld for press will be released at the beginning of the day on which the relevant press conference occurs.

Reporters, producers and editors agree to the embargoes and release times stated on the news releases, the news conference schedule and other materials. Failure to abide by the embargoes will result in suspension of credentials, which will affect attendance at the current and future symposia and ability to receive advance press materials.

By allowing an abstract to be included in the 2022 San Antonio Breast Cancer Symposium media outreach program, the Presenter verifies that the abstract’s contents and its conclusions have not been and will not be published or presented in any form to the public before the start of the actual presentation. This includes, but is not limited to, non-embargoed press releases and interviews required by government agencies. Any release of material and specific non-embargoed information prior to the meeting’s embargo date as set forth by the SABCS press office could result in exclusion from the official SABCS press program.

Proof of Attendance

A statement verifying your participation at the 2022 Symposium will be emailed to all attendees on Friday, December 9, 2022.

Certificate of Attendance/CME Certificate

Physicians seeking CME credit for this live continuing medical education activity or a Certificate of Attendance must complete the surveys for 2022 SABCS.  Surveys open on December 6, 2022 and close on January 31, 2023. The deadline to complete you session evaluations and post survey is January 31, 2023.